Within the first few weeks of the COVID-19 pandemic the health care industry was rocked by a telehealth explosion of Big Bang proportions. In just the first few weeks of 2020, virtual health visits experienced a decade of anticipated growth, according to Kyle Zebley, VP of public policy at the American Telemedicine Association (ATA).
The Pandemic Has Reshaped Telemedicine – And ‘There’s No Going Back’
The American Telemedicine Association has formed the Government Relations Special Interest Group to further the organization’s efforts to increase access to affordable virtual health.
More from Regulation
• By
The US FDA has published its final document to guide sponsors on using sex-specific data in designing clinical trials of medical devices. However, the guidance removes all references to gender that appeared in January’s draft guidance, released before the Trump administration took office.
• By
Calley Means defended reductions in force at the Health and Human Services Department that shocked and outraged federal workers and stakeholders.
• By
A seemingly humorous social media post on April Fool’s Day struck a nerve with regulatory experts, reflecting real concerns about recent actions by the US Food and Drug Administration.
• By
Mass FDA layoffs on 1 April were designed to spare product reviewers, but still touched many who are critical to the application review process or drug development, which could mean fewer treatments are brought to the US market first.